Table 2. S. pneumoniae serotypes isolated from SCD patients.
| Serotype | Overall N (%) |
Children N (%) |
Adult N (%) |
Serotype included in vaccine |
|---|---|---|---|---|
| 3 | 5 (5.9) | 4 (5.6) | 1 (7.1) | PCV13, PPV23 |
| 6A | 2 (2.4) | 2 (2.8) | 0 (0) | PCV13 |
| 6B | 9 (10.1) | 8 (11.3) | 1 (7.1) | PCV10, PCV13, PPV23 |
| 7F | 2 (2.4) | 1 (1.4) | 1 (7.1) | PCV10, PCV13, PPV23 |
| 8 | 2 (2.4) | 1 (1.4) | 1 (7.1) | PPV23 |
| 9A | 1 (1.2) | 1 (1.4) | 0 (0) | Non-vaccine serotype |
| 10A | 5 (5.9) | 3 (4.2) | 2 (14.3) | PPV-23 |
| 11A | 6 (7.1) | 5 (7.0) | 1 (7.1) | PPV-23 |
| 11D | 1 (1.2) | 1 (1.4) | 0 (0) | Non-vaccine serotype |
| 13 | 1 (1.2) | 1 (1.4) | 0 (0) | Non-vaccine serotype |
| 14 | 3 (3.5) | 3 (4.2) | 0 (0) | PCV10, PCV13, PPV23 |
| 15A | 3 (3.5) | 3 (4.2) | 0 (0) | Non-vaccine serotype |
| 15C | 4 (4.7) | 2 (2.8) | 2 (14.3) | Non-vaccine serotype |
| 16F | 2 (2.4) | 2 (2.8) | 0 (0) | Non-vaccine serotype |
| 17A | 1 (1.2) | 1 (1.4) | 0 (0) | Non-vaccine serotype |
| 17F | 1 (1.2) | 0 (0) | 1 (7.1) | PPV23 |
| 19B | 1 (1.2) | 1 (1.4) | 0 (0) | Non-vaccine serotype |
| 19F | 5 (5.9) | 5 (7.0) | 0 (0) | PCV10, PCV13, PPV23 |
| 21 | 1 (1.2) | 1 (1.4) | 0 (0) | Non-vaccine serotype |
| 23B | 7 (8.2) | 7 (9.9) | 0 (0) | Non-vaccine serotype |
| 23F | 4 (4.7) | 4 (5.6) | 0 (0) | PCV10, PCV13, PPV23 |
| 28F | 1 (1.2) | 0 (0) | 1 (7.1) | Non-vaccine serotype |
| 31 | 1 (1.2) | 1 (1.4) | 0 (0) | Non-vaccine serotype |
| 32F | 6 (7.1) | 6 (8.5) | 0 (0) | Non-vaccine serotype |
| 34 | 5 (5.9) | 4 (5.6) | 1 (7.1) | Non-vaccine serotype |
| 38 | 1 (1.2) | 0 (0) | 1 (7.1) | Non-vaccine serotype |
| Non-typeable | 5 (5.9) | 4 (5.6) | 1 (7.1) | Not applicable |
N- number; Total number of serotypes for children, adults and overall were 71, 14 and 85 respectively